Publications & News

Agios Pharmaceuticals Announces Closing of Over-Allotment Option in Public Offering

May 11, 2017

Agios Pharmaceuticals, Inc. announced that it has issued an additional 757,575 shares of common stock at the public offering price of $49.50 per share, for total gross proceeds of approximately $37 million, pursuant to the exercise in full of the underwriters' over-allotment option in connection with the company's previously announced public offering of common stock. After giving effect to the full exercise of the over-allotment option, the total number of shares sold by Agios in the public offering was 5,808,080 shares and gross proceeds were approximately $287 million.

The WilmerHale deal team representing Agios included Steve Singer, Cynthia Mazareas, Emily Gainor, and Killian Nolan.

Read Agios' press release for more information.